Commercial Strategy & M&A Advisory for MedTech Leaders
We help medical device companies scale across EMEA through go-to-market strategy, M&A due diligence, and interim executive leadership.
EUR 210M+
P&L Managed
27%
Revenue Growth Delivered
19%
Market Share Expansion
EUR 130M+
M&A Integrated
Experience from Molnlycke | Stryker | BD | Mediq
What We Do
Specialized advisory services for medical device companies, PE/VC investors, and healthcare innovators.
Commercial Strategy & Go-to-Market Advisory
Data-driven market entry and growth strategies for medical device companies expanding across EMEA.
Learn more →M&A Commercial Due Diligence
Commercial due diligence and value creation planning for PE funds and strategic acquirers in MedTech.
Learn more →Interim & Fractional Executive Leadership
Experienced interim CCO, Country Manager, or VP Commercial for MedTech organizations in transition.
Learn more →Digital Health & AI Commercialization Advisory
Commercialization strategy for digital health solutions, SaMD, and AI-enabled medical devices.
Learn more →How We Work
A structured approach to delivering measurable commercial impact.
Discovery
We listen to your challenge and context. Every engagement starts with understanding your business, market position, and strategic objectives.
Assessment
We diagnose the commercial opportunity. Through data analysis, stakeholder interviews, and market intelligence, we identify what matters most.
Strategy
We build a data-backed action plan. Clear priorities, measurable targets, and realistic timelines designed for your specific situation.
Execution
We stay to ensure results, not just reports. We work alongside your team to implement, adjust, and deliver tangible commercial outcomes.
Professional headshot
Shahram Khorsand
Founder & Managing Director
20+ years of MedTech commercial leadership. SSE MBA. Board member of Swedish Medtech. Helping medical device companies scale across EMEA.
- MBA, Stockholm School of Economics (SSE)
- MSc, Computer Engineering
- Board Member, Swedish Medtech (Sveriges Medicintekniska Forening)
Selected Work
Anonymized case studies from our commercial advisory engagements.
Nordic Market Entry for Surgical Device Company
Achieved 27% revenue growth in the first 18 months through a restructured go-to-market model.
Read case study →Commercial Due Diligence for PE Fund
Identified EUR 15M revenue upside through channel optimization, supporting a successful EUR 80M acquisition.
Read case study →Interim Country Manager for MedTech Distributor
Led organizational transformation and commercial integration of EUR 130M+ acquisition within 12 months.
Read case study →Insights
Perspectives on MedTech commercial strategy, M&A, and market dynamics.
5 Mistakes MedTech Companies Make Entering the Nordic Market
The Nordics look deceptively simple. Similar languages, high GDP, universal healthcare. But the commercial reality is more complex than most MedTech companies expect.
Read article →MDR is Reshaping European MedTech Distribution. Here is How.
The European Medical Device Regulation is not just a compliance exercise. It is fundamentally changing which products reach the market and through which channels.
Read article →Why Your MedTech PE Deal Needs Commercial Due Diligence
Financial models tell you what happened. Commercial due diligence tells you whether it will continue. For MedTech acquisitions, the difference is material.
Read article →Ready to scale your MedTech business across EMEA?
Whether you need a go-to-market strategy, commercial due diligence, or interim leadership, we are here to help.
Get in Touch